...
首页> 外文期刊>Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology >Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia.
【24h】

Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia.

机译:在脑衰老,阿尔茨海默氏病和血管性痴呆中的血清抗GFAP和抗S100自身抗体。

获取原文
获取原文并翻译 | 示例
           

摘要

Autoantibodies against glial fibrillary acidic protein (GFAP) and S100 protein were measured in sera of patients suffering from vascular dementia (VD), presenile Alzheimer's disease (AD), senile Alzheimer's disease (SDAT) and aged healthy controls by means of ELISA test. VD and SDAT showed the highest levels of both autoantibodies, AD the lowest. From these results a relationship between autoantibody titers and aging seems possible. Dosage of anti-GFAP and anti-S100 autoantibodies does not appear useful for diagnostic purpose because of the overlap observed among groups. Rather, the presence of these antibodies seems to reflect an alteration of the blood-brain barrier that promotes the access of central nervous system antigens to immunocompetent cells.
机译:通过ELISA测试,在患有血管性痴呆(VD),老年性阿尔茨海默氏病(AD),老年性阿尔茨海默氏病(SDAT)和老年健康对照的患者血清中测量了针对神经胶质纤维酸性蛋白(GFAP)和S100蛋白的自身抗体。 VD和SDAT两种抗体的水平最高,AD最低。从这些结果来看,自身抗体滴度与衰老之间的关系似乎是可能的。由于在各组之间观察到重叠,因此抗GFAP和抗S100自身抗体的剂量似乎无法用于诊断。相反,这些抗体的存在似乎反映了血脑屏障的改变,该改变促进了中枢神经系统抗原进入免疫功能细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号